Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 3/20 | 0.44 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MET | P08581 | 2/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21617155 | 1.00 | ROCK2 (0.44) | ROCK2PKN2CHRM4KCNH2SPHK2 | |
| SCHEMBL31504330 | 0.87 | CHRM4 (0.47) | CHRM4KCNH2 | |
| SCHEMBL21617167 | 0.87 | CHRM4 (0.47) | CHRM4KCNH2 | |
| SCHEMBL21617200 | 0.85 | CHRM4 (0.56) | CHRM4 | |
| SCHEMBL31504432 | 0.85 | CHRM4 (0.56) | CHRM4 | |
| SCHEMBL21617201 | 0.81 | GPR132 (0.44) | CHRM4 | |
| SCHEMBL31504383 | 0.81 | GPR132 (0.44) | CHRM4 | |
| SCHEMBL21617285 | 0.81 | HPGD (0.45) | CHRM4 | |
| SCHEMBL31504443 | 0.81 | HPGD (0.45) | CHRM4 | |
| SCHEMBL21617237 | 0.80 | GPR132 (0.44) | CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112638877-B | Phenyl/pyridinyl-N-phenyl/pyridinyl derivatives for the treatment of RNA viral infections | ABIVAX公司 | 2025-04-22 | — | — | CN | disclosed |